La Jolla Pharmaceutical Company
Financial ratios & Valuation

Historical Multiples (2012 – 2021)

2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 TTM Median
Valuation Ratios
Price/Earnings ratio
-0.11-0.20-9.23-10.08-3.86-5.94-1.20-0.91-2.688.0839.52-3.86
Price/Sales ratio
N/AN/AN/A399.78490.27N/A23.834.623.172.093.37N/A
Price/Book Value ratio
0.280.474.063.394.947.746.67-1.90-1.20-2.38-2.257.74
Price/Cash Flow ratio
-0.42-0.76-15.28-16.78-5.14-8.04-1.57-1.25-2.815.6211.94-5.14
Price/Free Cash Flow ratio
-0.42-0.76-14.98-15.65-4.95-7.25-1.54-1.24-2.815.6211.95-4.95
Price/Earnings Growth ratio
-0.00-0.110.09-0.29-0.05-0.31-0.020.020.04-0.050.31-0.05
Dividend Yield
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Profitability Indicator Ratios
Gross Profit Margin
N/AN/AN/A100%100%N/A83.66%89.62%76.60%82.18%80.93%N/A
Operating Profit Margin
N/AN/AN/A-3970.57%-12722.72%N/A-1929.70%-476.27%-107.23%39.84%-5.53%-12722.72%
Pretax Profit Margin
N/AN/AN/A-3965.18%-12692.37%N/A-1983.58%-505.37%-117.95%26.02%8.64%-12692.37%
Net Profit Margin
N/AN/AN/A-3965.18%-12692.37%N/A-1983.58%-505.37%-117.95%25.96%8.53%-12692.37%
Effective Tax Rate
N/AN/A-0.12%-0.13%-0.23%-0.54%-0.94%-3.49%-16.40%0.24%1.21%-0.23%
Return on Assets
-225.56%-205.04%-42.17%-32.40%-110.43%-96.03%-97.63%-88.09%-54.56%19.42%3.99%-110.43%
Return On Equity
-240.72%-234.35%-43.98%-33.65%-128.09%-130.15%-555.29%208.08%44.75%-29.45%-5.77%-128.09%
Return on Capital Employed
-334.13%-234.40%-44.04%-33.70%-128.40%-114.29%-111.61%-101.98%-59.82%36.08%-3.10%-128.40%
Liquidity Ratios
Current Ratio
15.877.9624.1626.466.915.075.953.962.95N/A4.025.07
Quick Ratio
15.767.8824.1626.466.915.075.883.872.463.463.305.07
Cash ratio
15.767.8823.3426.236.734.905.673.571.712.642.934.90
Days of Sales Outstanding
N/AN/AN/AN/AN/AN/A50.1246.8663.7141.5046.53N/A
Days of Inventory outstanding
N/AN/AN/AN/AN/AN/A448.75337.38280.69169.95341.77N/A
Operating Cycle
N/AN/AN/AN/AN/AN/A498.87384.24344.41211.46353.24N/A
Days of Payables Outstanding
N/AN/AN/AN/AN/AN/A1.90K637.37128.9361.6487.51N/A
Cash Conversion Cycle
N/AN/AN/AN/AN/AN/A-1.40K-253.13215.47149.8243.29N/A
Debt Ratios
Debt Ratio
0.060.12N/AN/AN/AN/AN/A0.220.000.021.69N/A
Debt Equity Ratio
0.060.14N/AN/AN/AN/AN/A-0.52-0.00-0.03-2.43N/A
Long-term Debt to Capitalization
N/AN/AN/AN/AN/AN/AN/A-0.89-0.00-0.00-0.00N/A
Total Debt to Capitalization
N/AN/AN/AN/AN/AN/AN/A-1.09-0.00-0.04-0.00N/A
Interest Coverage Ratio
N/AN/AN/AN/AN/AN/A-26.57-10.19-3.56N/A-0.25N/A
Cash Flow to Debt Ratio
N/AN/AN/AN/AN/AN/AN/A-2.90-70.2210.6856.60N/A
Company Equity Multiplier
1.061.141.041.031.151.355.68-2.36-0.82-1.51-1.431.35
Cash Flow Ratios
Operating Cash Flow / Sales Ratio
N/AN/AN/A-23.82-95.24N/A-15.15-3.68-1.120.370.28-95.24
Free Cash Flow / Operating Cash Flow Ratio
11.001.021.071.031.101.011.0010.990.991.10
Cash Flow Coverage Ratio
N/AN/AN/AN/AN/AN/AN/A-2.90-70.2210.6856.60N/A
Short Term Coverage Ratio
N/AN/AN/AN/AN/AN/AN/A-30.71-184.5011.3983.64N/A
Dividend Payout Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A